Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Orexigen Therapeutics Inc (NASDAQ:OREX)

1.62
Delayed Data
As of 4:00pm ET
 -0.02 / -1.22%
Today’s Change
1.55
Today|||52-Week Range
5.70
-6.90%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Revenue and IncomeNet Revenues13.9M19.1M23.4M18.9M
 
 
 
 
 
Cost of Goods Sold4.2M6.1M6.7M4.0M
 
 
 
 
 
Depreciation And Amortization2.0M2.1M2.1M--
 
 
 
 
 
Operating ExpensesGross Income7.7M11.0M14.5M14.9M
 
 
 
 
 
General Expenses48.7M63.4M55.8M36.1M
 
 
 
 
 
Other Operating Expenses0.000.000.002.0M
 
 
Research And Development6.7M8.2M7.5M5.8M
 
 
 
 
 
Total Operating Expenses54.8M71.6M64.6M42.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-40.9M-52.4M-41.3M-23.3M
 
 
 
 
 
Extraordinary Credit26.0M12.3M6.0M0.00
 
 
 
 
Extraordinary Charge-2.0M-29.4M-700.0K-128.0K
 
 
 
 
 
Interest Expense On Debt2.0M1.2M863.0K794.0K
 
 
 
 
 
Other Expenses-5.6M1.5M6.3M3.2M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-24.5M-69.1M-30.5M-20.8M
 
 
 
 
 
Income Taxes-133.0K0.000.00--
 
 
Net Income-24.6M-69.1M-30.5M-20.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS14.6M14.8M15.2M15.4M
 
 
 
 
 
Shares To Calculate EPS Diluted14.6M14.8M15.2M15.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.69-$4.67-$2.00-$1.35
 
 
 
 
 
EPS Diluted-$1.69-$4.67-$2.00-$1.35